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Abstract We have identified Ser-1275 and Ser-1309 as novel 
serine autophosphorylation sites by direct sequencing of HPLC-
purified tryptic phosphopeptides of the histidine-tagged insulin 
receptor kinase IRKD-HIS. The corresponding peptides (Ser-
1275, amino acids 1272-1292; Ser-1309, amino acids 1305-
1313) have been detected in the HPLC profiles of both the 
soluble kinase IRKD, which contains the entire cytoplasmic 
domain of the insulin receptor ß-subunit, and the insulin receptor 
purified from human placenta. In contrast, a kinase negative 
mutant, ERKD-K1018A, did not undergo phosphorylation at 
either the tyrosine or serine residues, strongly suggesting that 
insulin receptor kinase has an intrinsic activity to autophos-
phorylate serine residues. 
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1. Introduction 
The monomeric enzyme derived from the cytoplasmic por-
tion of the human insulin receptor has been shown to exhibit 
comparable catalytic properties and identical tyrosine auto-
phosphorylation sites to the native receptor [1-8]. In addition 
to tyrosine autophosphorylation of the purified insulin recep-
tor, it has been shown that the ß-subunit of the insulin recep-
tor (IR) undergoes serine phosphorylation. The attempts of 
our group and others to separate the serine kinase activity 
from tyrosine kinase activity [9-11] have led to the conclusion 
that highly purified insulin receptors contain an intrinsic in-
sulin-dependent serine kinase activity. Moreover, serine phos-
phorylation was shown to be sensitive to an apparent specific 
tyrosine kinase inhibitor [10] and occurred independently of 
the purification state of the receptor [11]. These data have 
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strengthened the hypothesis that the serine kinase activity is 
indeed an intrinsic property of the insulin receptor. The aim 
of our study was to localize the sites of serine autophosphor-
ylation in vitro by direct sequencing of the corresponding 
peptides of the kinase and to compare these sites with serine 
phosphorylation sites of the holoreceptor. Therefore, we over-
expressed the soluble insulin receptor kinase in insect cells. 
The construction of two different forms of the kinase enabled 
us to purify the enzymes using alternative protocols. Further-
more, we examined serine phosphorylation in a kinase defi-
cient mutant, in which tyrosine autophosphorylation was ab-
sent. 
2. Materials and methods 
[γ-32Ρ]ΑΤΡ (6000 Ci/mmol) was obtained from Amersham. Restric-
tion endonucleases and ATP were from Boehringer Mannheim. Cell 
culture reagents were from Life Technologies Inc.; poly(L-lysine) (Afr 
6000-9000) was from Serva. Tryptic peptides for sequencing reactions 
were generated with modified trypsin (sequencing grade) from Prome-
ga. For HPLC phosphopeptide maps, trypsin (sequencing grade) from 
Merck was used. Other reagents were obtained from common com-
mercial sources. 
2.1. Construction of soluble insulin receptor kinases 
Construction of the histidine-tagged kinase (IRKD-HIS, 49 kDa) 
and IRKD was previously described [6,7]. IRKD-K1018A: The ami-
no acid Lys-1018, involved in the ΑτΡ-binding site of the insulin 
receptor [12,13], was substituted by alanine by site-directed mutagen-
esis of the cDNA using unique site elimination [14]. A mutagenesis 
primer was constructed (5'-GTGGCGGTGGCGACGGTTAACGA-
GTCAGC-3') which in addition to the amino acid substitution cre-
ated a new Hpal site in the insulin receptor cDNA. A second primer 
was used as a selection primer (5'-GAGTGCACCATGGGCGGT-
GTGAAAT-3'), to eliminate an Ndel site in pUC19. The mutagenesis 
reaction, using pUC-IRKD as a template was performed according to 
the manufacturer's instructions (Clonetech). The mutated region was 
sequenced to ensure that no other mutation had occurred. The XhoV 
BstXl fragment, containing the mutation was isolated to replace the 
corresponding fragment in pUC-IRKD. Construction of the baculo-
virus transfer vector was performed as described for the IRKD. Spo-
doptera frugiperda (Sf9) cells were cotransfected with Autographa ca-
lifornica nuclear polyhedrosis virus (AcNPV) DNA and transfer 
vectors using the BaculoGold System (Pharmingen) according to the 
manufacturer's instructions. Recombinant viruses were isolated by 
performing plaque assays [15]. 
2.2. Purification of soluble insulin receptor kinases 
Purification of the soluble kinases was accomplished by sequential 
chromatography using MonoQ and Phenyl-Sepharose (Pharmacia). 
Alternatively, the histidine-tagged kinase could be purified by immo-
bilized metal chelate affinity chromatography on Ni-NTA agarose 
(Qiagen) and FPLC phenyl-Sepharose chromatography [7]. 
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2.3. Purification of the insulin receptor from human placenta 
Purification of the human insulin receptor was performed as de-
scribed [11]. In brief, the receptors were solubilized with Triton X-
100 from placental membranes and affinity purified by successive 
chromatography on insulin agarose, wheat germ agglutinin Sepharose 
and hydroxyapatite. 
2.4. Phosphorylation reactions 
All phosphorylation reactions were carried out at room temperature 
(22°C). For the soluble kinases the reaction mixtures contained 50 
mM Tris-HCl, pH 7.5, 5 mM MgCl2, 5 mM MnCl2, 1 μΜ poly(ly-
sine) and 250 μΜ [γ-32Ρ]ΑΤΡ. Unless otherwise indicated, the concen-
tration of the kinase was 1 μΜ. Phosphorylation reaction of the 
purified human insulin receptor were carried out in 30 mM HEPES, 
pH 7.2, 10 mM MgCl2, 0.5 mM MnCl2, 200 μΜ fr
32P]ATP, 0.1 μΜ 
insulin and 0.05% Triton X-100. The receptor was incubated on ice 
with insulin for 30 min and added to the reaction mixture to a final 
concentration of ~0 .1 μΜ. The proteins were separated by SDS-
PAGE, localized by autoradiography and the radioactivity of the ex-
cised bands was determined by measurement of Cerenkov radiation in 
a Beckman scintillation counter. 
2.5. Digestion with trypsin 
The autophosphorylated soluble kinases and the insulin receptor β-
subunit were located on SDS-PAGE by autoradiography of the fixed 
and dried gels and the corresponding bands were excised. In-gel diges-
tion of the proteins was performed according to [16,17]. The recovery 
of 32P typically exceeded 90%. For preparative scale reactions, the 
autophosphorylated IRKD-HIS was precipitated by addition of tri-
chloroacetic acid to a final concentration of 10%. After centrifugation, 
the pellet was washed twice with absolute ethanol and resuspended in 
100 mM Tris-HCl pH 8.0, 1 mM CaCl2 to yield a protein concentra-
tion of 1 mg/ml. Trypsin was added (1/20, w/w) and the reaction 
mixture was incubated at 37°C for 16 h. 
2.6. Separation of tryptic phosphopeptides 
Initially, phosphopeptides were separated with a Shimadzu HPLC 
system using an anion exchange column (Macherey and Nagel, Nu-
cleogel SAX-1000-8/46). The buffers used were (A) 20 mM ammo-
nium acetate, pH 7.0 and (B) 1 M potassium phosphate, pH 4.O. 
The phosphopeptides were injected onto the column at a flow rate 
of 0.5 ml/min. Elution of the phosphopeptides was achieved by apply-
ing a two-step linear gradient (0-10% B in 40 min; 10-50% B in 80 
min) to the column. Fractions of 0.5 ml (1 min) were collected in 
polypropylene tubes and the radioactivity in each tube was measured 
as Cerenkov radiation in a Beckman scintillation counter. The recov-
ery of 32P typically was 75-90%. For rechromatography, an Applied 
Biosystems HPLC system was used. The phosphopeptides from the 
anion exchange chromatography were separated by reversed-phase 
HPLC using a microbore Cis column (SGE, Weiterstadt, Germany). 
The samples were adjusted to 0.1% trifluoroacetic acid (TFA) and 
applied to the column at a flow rate of 0.1 ml/min. A linear gradient 
of 0.1% TFA vs. 80% acetonitrile/0.1% TFA in 30 min at a flow rate 
of 0.1 ml/min was used for elution of the peptides. Elution was mon-
itored by measuring the absorption at 215 and 295 nm in a 32 μΐ flow-
through cuvette and fractions of 25-100 μΐ were collected by hand. 
After determination of Cerenkov radiation, the radioactive fractions 
were subjected to sequence analysis. 
2.7. Sequence analysis of tryptic phosphopeptides 
Phosphoserines were modified to S-ethylcysteines according to the 
procedure previously described [18,19]. The amino acid sequences 
were determined by automated Edman degradation in an Applied 
Biosystems, Inc. (ABI; Foster City, CA) model 470A protein sequenc-
er. Phosphotyrosine-containing peptides were sequenced on an ABI 
model 473A Sequenator. The presence of PTH-phosphotyrosine was 
confirmed by capillary electrophoresis of aliquots of each sample from 
the sequenator [20]. Matrix-assisted laser desorption/ionization time-
of-flight mass spectrometry (MALDI-TOF-MS) of purified phospho-
peptides was performed as described [21]. 
2.8. Phosphoamino acid analysis 
Tryptic phosphopeptides were lyophilized in a Speed-Vac, hydro-
lyzed in 100-200 μΐ of 6 N HC1 at 110°C for 1.5 h, diluted with 500 μΐ 
of water and dried. Two dimensional phosphoamino acid analysis was 
performed by electrophoresis as described by Boyle et al. [22]. Quan-
tification of phosphoamino acids was achieved by using a Phospho-
Imager (Fuji BAS1000). 
2.9. Other procedures 
S. frugiperda (Sf9) cells were maintained as described [15]. Protein 
concentrations were determined by a modified method of Bradford 
[23]. SDS-PAGE was performed according to Laemmli [24]. 
3. Results 
3.1. Construction, expression and purification of soluble insulin 
receptor kinases 
We have overexpressed two forms of soluble insulin recep-
tor kinases ( IRKD) in insect cells with different N-termini : (i) 
a histidine-tagged kinase ( IRKD-HIS) of 49 k D a (Gly-947-
Ser-1343 [7]); (ii) a 45 k D a kinase ( I R K D ) containing the 
entire cytoplasmic domain of the insulin receptor ß-subunit 
(Arg-941-Ser-1343 [6]). In addition, we have overexpressed a 
Table 1 
Sequence analysis results of purified tryptic phosphopeptides derived from the IRKD-HIS 
Amino acid sequence of phosphopeptides" Proreceptor residue no.b Phosphorylated residues Fraction0 Domaind 
APESpEELEMEFEDM(E)NVPLDR 
DGGSSpLGFK 
DLYpDDDDKDRe 
DLYpDDDDKe 
DIYpETDYpYpR 
DIYpETDYpYpR 
SYpEEHIPYTHMNGGK 
SYpEE(H)IPY 
SYEEHIPYpTHMNGGK 
SYEE(H)I(P)YpT(H)MN 
SYpEEHIPYpTHMNGGK 
SYpEEHIPYp 
1272-1292 
1305-1313 
1144-1152 
1315-1329 
Ser-1275e 
Ser-1309e 
Tyr-26f 
Tyr-26f 
Tyr-1146/1150/1151 (partial) 
Tyr-1146/1150/1151 (tris) 
Tyr-1316 
Tyr-1316 
Tyr-1322 
Tyr-1322 
Tyr-1316/1322 (bis) 
Tyr-1316/1322 (bis) 
[y-32P]ATP 
m 
b 
J 
k 
h 
n 
f 
d 
d 
c 
g 
e 
1 
CT 
NT 
CD 
CT 
aA 'p ' denotes phosphorylation of the preceding amino acid residue. Residues in parentheses yielded no PTH-amino acid signal. 
bNumbering according to Ullrich et al. [13]. 
Tractions from HPLC anion exchange chromatography (see Fig. 2A). 
"-Location of the corresponding peptide in the insulin receptor kinase; CT, C-terminal domain; CD, catalytic domain; NT, heterologous N-
terminus of the kinase. 
e Sequence analysis was repeated twice in independent experiments (enzyme purification, autophosphorylation reaction, isolation and separation of 
the phosphorylated peptides). 
'Sequence derived from the baculovirus transfer vector. 
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Fig. 1. Autophosphorylation of the soluble insulin receptor kinases 
and phosphoamino acid analysis. The purified kinases were auto-
phosphorylated for 30 min, separated by SDS-PAGE and analyzed 
for phosphoamino acid composition. (A) Coomassie stained SDS-
PAGE of the purified kinases (1 μg each; lanes 1-3) and autoradio-
graphy of the autophosphorylated kinases (lanes 4-6). IRKD-HIS 
(lanes 1,4), IRKD-K1018A (lanes 2,5), IRKD (lanes 3,6). Specific 
phosphate incorporation was 5 mol/mol for the IRKD-HIS and 4.5 
mol/mol for the IRKD). (B) Two-dimensional phosphoamino acid 
analysis of the kinases. Relative serine/threonine phosphorylation 
was 17% for the IRKD-HIS and 15% for the IRKD. 
45 kDa kinase deficient mutant of the IRKD (IRKD-
K1018A). The three proteins were expressed in comparable 
amounts after infection of Sf9 cells with the recombinant bá-
culo viruses (data not shown). The soluble enzymes were pur-
ified by anion exchange chromatography (MonoQ) followed 
by hydrophobic chromatography (phenyl-Sepharose). Alter-
natively, the IRKD-HIS could be purified by a protocol 
that made use of metal chelate affinity chromatography (Ni-
NTA agarose) followed by hydrophobic chromatography. 
The two different purification protocols yielded comparable 
results for the histidine-tagged kinase. The enzymes were pur-
ified to > 95% homogeneity based upon density evaluation of 
Coomassie stained gels with an overall yield of ~0.75 mg/108 
cells, corresponding to ~ 5% of the total soluble protein (Fig. 
1A, lanes 1-3). 
3.2. Autophosphorylation of the insulin receptor kinases 
In order to characterize the purified IRKD-HIS and IRKD 
we carried out autophosphorylation reactions [25]. Phosphate 
incorporation was 4.5-5 and 4-4.5 mol/ mol after 30 min of 
autophosphorylation for the IRKD-HIS and IRKD, respec-
tively (Fig. 1 A, lanes 4,6). Although the amount of phosphate 
incorporated by the two kinases was slightly different, the 
enzymes exhibited almost identical specific activities for the 
phosphorylation of exogenous substrates (data not shown). 
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As expected the kinase deficient mutant, IRKD-K1018A, 
did not show any phosphate incorporation. This demonstrates 
that this kinase was both an inactive enzyme and free of any 
contaminating kinase activities (Fig. 1A, lane 5) whether tyro-
sine or serine specific. The phosphoamino acid analysis of the 
autophosphorylation reaction of the active soluble kinases 
showed a phosphoserine content of ~ 15%. In addition, traces 
( ~ 3%) of phosphothreonine were detected in the IRKD-HIS. 
However, it should be noted that phosphoserine and phos-
photyrosine may exhibit different stabilities during acid hy-
drolysis of phosphopeptides [26]. The extent of serine/threo-
nine phosphorylation of the IRKD-HIS was independent of 
the purification protocol (Ni-NTA agarose instead of 
MonoQ). 
3.3. Localization of the serine/threonine phosphorylation sites 
To identify the serine/threonine phosphorylation sites of the 
histidine-tagged kinase IRKD-HIS, the autophosphorylated 
enzyme was digested with trypsin, and the resultant tryptic 
peptides were resolved by anion exchange HPLC. The tryptic 
digest was separated into 14 major radioactive peaks with a 
total recovery of 90% of radioactivity loaded on the column. 
The radioactive fractions were pooled according to the radio-
activity profile (Fig. 2A) and aliquots from each fraction were 
analyzed for their phosphoamino acid composition by two-
dimensional electrophoresis. Two of these fractions (b and m 
in Fig. 2A) contained peptides which were entirely phosphory-
lated at serine residues. Both fractions were applied to re-
versed-phase HPLC chromatography each yielding only one 
major radiolabeled peptide (Fig. 2B,C). Finally, the resulting 
peptides were subjected to automated Edman degradation. 
2.5 
P 
P 
9. 0.5 , 
o μ ^ m$\ 
, i-
,-■■''' ¡\k m 
' · ' V Λ 
h '■ 
" N v\J\i 
40 60 80 
Fraction number 
50 
40 
30 | 
- 20 | 
o 
CO 
10 
— 0 
100 
jl.iAk.1.«, 
100 
80 , 
60 a 
40 S 
20 " 
0 
20 40 
Time (min) 
0.25 r 
0.2 [ 
0.15 
0.1 
0.05 -
0 ¿ -
100 
80 „ 
60 ω 
40 | 
o 
CO 
20 
0 
0 20 40 60 
Time (min) 
Fig. 2. Separation of tryptic digest and isolation of serine phos-
phorylated peptides. 8 nmol IRKD-HIS were autophosphorylated 
for 30 min in the presence of 250 μΜ [γ-32Ρ]ΑΤΡ and digested with 
trypsin. (A) HPLC anion exchange chromatography of tryptic di-
gest. Radioactive fractions were pooled (solid bars) and aliquots 
were analyzed for phosphoamino acid composition (not shown). 
Fractions b and m contained peptides phosphorylated entirely on 
serine residues. (B,C) Cis reversed phase rechromatography of phos-
phoserine-containing fraction b (B) and fraction m (C). 
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Fig. 3. Comparison of phosphopeptide mapping of the kinase nega-
tive mutant IRKD-K1018A and the active kinases. (A) Phosphory-
lation of the kinase negative mutant (IRKD-K1018A) with IRKD-
HIS. Autoradiography of phosphorylated IRKD-HIS (lane 1), 1 μΜ 
IRKD-K1018A (lane 2), 5 μΜ IRKD-K1018A (lane 3), phosphoryl-
ated IRKD (lane 4). Phosphorylation reactions were carried out for 
30 min (lanes 1-3) and for 5 min (lane 4) and separated by SDS-
PAGE. (B) Two-dimensional phosphoamino acid analysis of IRKD 
and mutant kinase IRKD-K1018A. (C) HPLC anion exchange chro-
matography of tryptic digest from phosphorylated IRKD, IR and 
IRKD-K1018A. The active enzymes (1-2 μg) were autophosphoryl-
ated for 30 min and separated by SDS-PAGE. Substrate phospho-
rylation of IRKD-K1018A was obtained as described above (A). 
The proteins were digested with trypsin and phosphopeptides (~105 
cpm) were separated by HPLC anion exchange chromatography. 
Arrows denote the phosphoserine-containing fractions, correspond-
ing to Ser-1275 (right) and Ser-1309 (left). 
The phosphoserine-containing peptides were sequenced after 
transformation of phosphoserine to S-ethylcysteine in order to 
prevent ß-elimination during Edman degradation [18,19]. Ta-
ble 1 summarizes the identified phosphorylation sites of the 
tryptic phosphopeptides. Two phosphoserine-containing pep-
tides of the IRKD-HIS were identified: (i) peptide of fraction 
b corresponding to amino acid sequence 1305-1313 
(DGGSS*LGFK) which yielded an S-ethylcysteine signal in 
cycle number 5 (asterisk) and (ii) peptide of fraction m corre-
sponding to amino acid sequence 1272-1292 (APES*EELEM-
EFEDMENVPLDR) where serine in position 4 was converted 
to S-ethylcysteine. Thus, Ser-1275 and Ser-1309 were the 
phosphorylated residues in the soluble kinase IRKD-HIS. 
As illustrated in Fig. 2A, each of the two peptides contained 
about equal amounts of radioactivity. None of the two serines 
have been previously described as potential autophosphoryla-
tion sites of the insulin receptor kinase. In addition to serine 
phosphorylation, only the IRKD-HIS is phosphorylated on 
threonine residues (Fig. IB). We detected the corresponding 
threonine phosphorylated peptide in the breakthrough of the 
anion exchange chromatography. According to sequence anal-
ysis and matrix assisted laser desorption/ionization time-of-
flight mass spectrometry (MALDI-TOF-MS), this peptide 
has been derived from the baculovirus transfer vector pBlue-
BacHIS (residues 1-23; MRGSHHHHHHGMASMTGGQQ-
MGR; Thr-16 phosphorylated). 
3.4. Localization of the tyrosine phosphorylation sites 
For a comparison of phosphopeptide patterns of the differ-
ent insulin receptor kinases (IRKD-HIS, IRKD and IRKD-
K1018A), as well as of the native insulin receptor purified 
from human placenta, we identified the major peaks from 
HPLC-anion exchange chromatography. We sequenced the 
tyrosine phosphorylated peptides from the IRKD-HIS corre-
sponding to the catalytic domain (Tyr-1146, Tyr-1150, Tyr-
1151) and the C-terminal region (Tyr-1316, Tyr-1322; cf. Fig. 
2A, Table 1), as described by others [1,27-30]. 
3.5. Comparison of phosphopeptide mapping of the kinase 
negative mutant IRKD-K1018A and the active kinases 
We have studied the phosphorylation of the negative mu-
tant kinase as a substrate and the histidine-tagged kinase as 
the catalyst in a substrate phosphorylation reaction. Besides 
the differences in the catalytic properties, both enzymes are 
distinct due to the histidine tag in the IRKD-HIS. Taking 
advantage of the different molecular mass of the histidine-
tagged kinase (49 kDa) and the kinase negative mutant (45 
kDa), we were able to separate the proteins by SDS-PAGE 
after the phosphorylation reactions. In addition to the auto-
phosphorylation of the catalyst the substrate was efficiently 
phosphorylated (Fig. 3A). Multiple bands of the phosphoryl-
ated kinase negative mutant most likely arise from different 
binding of SDS to partially phosphorylated forms of the pro-
tein. The IRKD-K1018A incorporated about 3.5 mol phos-
phate/mol within 30 min of reaction time. However, phos-
phoamino acid analysis of the mutant kinase revealed only 
traces of phosphoserine ( < 1%) (Fig. 3B). In order to localize 
the phosphorylation sites of the substrate, tryptic phospho-
peptides derived from the IRKD-K1018A were separated by 
anion exchange HPLC. Fig. 3C shows representative phos-
phopeptide maps of the mutant kinase and the corresponding 
active kinases (i.e. IR and IRKD). Obviously, all profiles are 
very similar. Thus, all tyrosine phosphorylation sites of the 
kinase-negative mutant were accessible to phosphorylation by 
the histidine-tagged kinase, although the corresponding serine 
phosphorylated peptides are absent. Most importantly, serine 
phosphorylation of the human insulin receptor [11] and the 
IRKD (Fig. IB) results in the appearance of two peptides 
(Fig. 3C; marked by arrows) phosphorylated on serine resi-
dues exclusively that correspond to the identified phosphoser-
ine peptides of the IRKD-HIS. Thus, our data strongly sug-
gests, that Ser-1275 (peptide 1272-1292) and Ser-1309 
(peptide 1305-1313) are also the major serine autophospho-
rylation sites in vitro of the human insulin receptor as well as 
of the soluble insulin receptor kinases. No significant serine/ 
threonine phosphorylation was detected in any other peak. 
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4. Discussion 
Recent reports have discussed serine/threonine autophos-
phorylation of the insulin receptor kinase [9-11]. In this study 
we have identified two serine phosphorylation sites in the in-
sulin receptor kinase in vitro. Additionally, we present strong 
evidence that these phosphoserines are derived from auto-
phosphorylation reactions due to the intrinsic serine/threonine 
kinase activity of the protein tyrosine kinase. To ascertain 
whether the receptor kinase is indeed a dual specificity kinase 
capable of phosphorylating serine as well as tyrosine residues 
[31], we made use of two independent strategies (i.e. ion ex-
change chromatography and immobilized metal chelate affin-
ity chromatography) to purify the two versions of the recom-
binant protein kinases. In both cases, the purified enzymes 
undergo autophosphorylation at the tyrosine and serine resi-
dues. The major sites of serine autophosphorylation were 
identified by sequence analysis of HPLC-purified tryptic phos-
phopeptides of the histidine-tagged kinase, IRKD-HIS. The 
two phosphopeptides that combined exclusively phosphoser-
ine, were both derived from the carboxy terminus: a highly 
negatively charged 21 amino acid peptide (residues 1272-
1292) and a nonapeptide (residues 1305-1313). Within these 
peptides Ser-1275 and Ser-1309 were identified by direct se-
quencing of S-ethylcysteine derivatives of the corresponding 
phosphopeptides. Moreover, our data strongly suggests that 
Ser-1275 and Ser-1309 constitute the major sites of serine 
autophosphorylation of the soluble kinase lacking the stretch 
of histidines, and the purified human insulin receptor. A com-
parison of the tryptic HPLC maps of the kinases proved this. 
These peptides are absent in the HPLC map of the kinase 
negative mutant that has been applied in substrate phospho-
rylation with IRKD-HIS. 
In previous studies, serine residues 1293 and/or 1294 have 
been proposed as sites of insulin-stimulated receptor phos-
phorylation [10]. Following their phosphorylation in vitro 
by highly purified insuhn receptors, synthetic peptides based 
on the receptor sequence surrounding these residues 
(-SSHCQR-) comigrate during HPLC with the 32P-labeled 
insulin receptor tryptic peptide phosphorylated in intact cells 
[4] or in vitro phosphorylated after affinity purification [10]. 
Serine residues 1293 and/or 1294 are potential sites of insulin 
stimulated receptor phosphorylation; however, this site may 
represent only a minor fraction of the total serine content of 
the receptor. 
Ellis and his colleagues have reported serine phosphoryla-
tion of a partially purified soluble insulin receptor kinase [4]. 
Two-dimensional phosphopeptide mapping revealed 2 serines 
that are phosphorylated in considerable amounts in the 48 
and 43 kDa soluble kinase derivatives, but not in the 38 
kDa kinase, derived by limited tryptic proteolysis of the 48 
kDa kinase. The absence of serine phosphorylation within the 
truncated receptor kinase species (38 kDa) strongly suggests 
that serine phosphorylation takes place in the carboxy-termi-
nus. Moreover, one of the phosphoserine peptides has a mo-
bility similar to that of the phosphoserine-containing peptide 
derived from an in vivo phosphorylated native receptor ß-
subunit. In addition, the authors identified a highly negatively 
charged peptide, which was exclusively phosphorylated on 
serine. However, the amino acid sequence of this peptide 
has not been determined. With regard to the highly negative 
charges it appears similar to one of our sequenced phospho-
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serine peptides (peptide m) including Ser-1275 as phosphoryl-
ation site. The extent of kinase serine autophosphorylation 
observed in these studies is between 15 and 25% of the total 
autophosphorylation of the kinases. Serine phosphorylation 
reactions are delayed relative to the kinase tyrosine phospho-
rylation [10,11]. Under our experimental conditions, Í1/2 for 
half-maximal tyrosine incorporation is 0.5 min, whereas t\¡i 
for half-maximal serine autophosphorylation is in the order of 
5 min (data not shown). Studies with a degenerate peptide 
library [32] indicate that the insulin receptor displays a pref-
erence for phosphorylating tyrosines downstream of the acidic 
residues. Thus, considering the physical and biochemical data, 
it seems unlikely that the observed serine/threonine phospho-
rylation results from a direct phosphoryl transfer from ATP 
to the hydroxyl groups of serine/threonine residues [33]. This 
is in agreement with the low level of serine phosphorylation 
that we observed when utilizing the inactive kinase, IRKD-
K1018A, as a substrate. 
In previous studies, we [7] and others [34] have reported 
that the insulin receptor kinase is able to auto-dephosphoryl-
ate tyrosine autophosphorylation sites. Under pulse-chase 
conditions, it is evident that the enzyme is capable of transient 
phosphorylation of certain tyrosine residues [7]. Although 
highly speculative, it may be proposed that the observed ser-
ine/threonine phosphorylation is due to an intramolecular 
phosphoryl transfer (ciy-phosphorylation), most probably 
from transient tyrosine phosphates to serine residues. Further 
studies on the serine/threonine kinase activity of the insuhn 
receptor kinase are in progress to elucidate the reaction mech-
anism of the enzyme. 
To summarize, our data strongly suggest that the receptor 
kinase has an intrinsic serine kinase activity by the following 
observations: (i) The autophosphorylation of the purified ac-
tive kinases (IRKD-HIS and IRKD) and the purified human 
insulin receptor [9,11] both resulted in phosphorylation of the 
serine residues. After 30 min, serine phosphorylation reached 
a stoichiometry of up to 1.0 mol phosphate per mol of kinase 
or ß-subunit. (ii) Serine autophosphorylation occurred inde-
pendently of the protocol performed to purify the kinase. (iii) 
The kinase negative mutant IRKD-K1018A, purified under 
the same conditions as the active kinases, was not phosphoryl-
ated on serine residues. In addition, one could argue that an 
exogenous serine kinase requires (i) activation by tyrosine 
phosphorylation and/or (ii) acts only on the tyrosine phos-
phorylated insulin receptor kinase. However, the most conclu-
sive evidence for the intrinsic serine kinase activity of the 
insulin receptor kinase results from experiments with the ki-
nase negative mutant. This kinase was phosphorylated as a 
substrate on tyrosine residues but only traces of serine phos-
phate were detected ( < 1% of labeled phosphate incorpora-
tion). Thus, we present direct evidence for the ability of the 
insulin receptor kinase to autophosphorylate on both tyrosine 
and serine/threonine residues. In support of our findings, 
Tauer et al. [35], through the expression of the insulin receptor 
with a recombinant vaccinia virus, also conclude that the ser-
ine kinase activity is a part of the insulin receptor. 
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